Communiqués Matricelf Ltd

Actions

Marché Fermé - TEL AVIV STOCK EXCHANGE Autres places de cotation 12:44:47 26/06/2026			Varia. 5j.	Varia. 1 janv.
284,90 ^ILa	-1,93 %		+3,68 %	-48,28 %

22/06	Matricelf lance une étude d'efficacité pré-IND pour son implant de tissu neural humain destiné aux lésions chroniques de la moelle épinière	CI
17/06	Matricelf achève son étude de sécurité BPL pour son implant de tissu neural d'ingénierie	CI

23/06	Matricelf Initiates IND Enabling Efficacy Study Following Positive Preclinical Results in Spinal Cord Injury	AQ
03/03	Matricelf Ltd. (TASE: MTLF) Signs MOU to Establish Subsidiary for Commercialization of Parkinson's Disease Therapy	PR
02/03	Matricelf Ltd. (TASE: MTLF) Appoints Ron Mayron as Chairman of the Board	AQ
27/02	Matricelf Ltd. (TASE: MTLF) Appoints Ron Mayron as Chairman of the Board	PR
26/02	Matricelf Ltd. (TASE: MTLF) Reports 2025 Milestones and Outlines 2026 Strategic Roadmap Toward First-in-Human Spinal Cord Implantation	PR
21/08/25	Tel Aviv University: Israeli Breakthrough: First Human Trial of Engineered Spinal Cord	AQ
12/03/25	Cellino and Matricelf, New Hope for Spinal Cord Injuries	AQ
11/03/25	Cellino and Matricelf Announce Global Collaboration to Scale Personalized Spinal Cord Injury Treatments	BU
27/03/24	Matricelf : INVESTORS PRESENTATION	PU